{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:41:16Z","timestamp":1771587676859,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06025-2","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T19:05:08Z","timestamp":1609787108000},"page":"791-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II"],"prefix":"10.1007","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-4007","authenticated-orcid":false,"given":"Mia M.","family":"Gaudet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Deubler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ryan","family":"Diver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Puvanesarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Gansler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Gapstur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"6025_CR1","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/jnci\/91.23.2020","volume":"91","author":"PL Porter","year":"1999","unstructured":"Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020\u20132028","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR2","doi-asserted-by":"crossref","first-page":"e110207","DOI":"10.1371\/journal.pone.0110207","volume":"9","author":"J Blanch","year":"2014","unstructured":"Blanch J, Sala M, Ibanez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rue M, Salas D, Group IS (2014) Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS ONE 9:e110207","journal-title":"PLoS ONE"},{"key":"6025_CR3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10549-019-05322-9","volume":"177","author":"S Puvanesarajah","year":"2019","unstructured":"Puvanesarajah S, Gapstur SM, Patel AV, Sherman ME, Flanders WD, Gansler T, Troester MA, Gaudet MM (2019) Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in cancer prevention study-ii. Breast Cancer Res Treat 177:679\u2013689","journal-title":"Breast Cancer Res Treat"},{"key":"6025_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jcp.53.2.140","volume":"53","author":"WK Cowan","year":"2000","unstructured":"Cowan WK, Angus B, Gray JC, Lunt LG, Al-Tamimi SR (2000) A study of interval breast cancer within the nhs breast screening programme. J Clin Pathol 53:140\u2013146","journal-title":"J Clin Pathol"},{"key":"6025_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0960-9776(03)00169-3","volume":"13","author":"PG Gill","year":"2004","unstructured":"Gill PG, Farshid G, Luke CG, Roder DM (2004) Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer. Breast 13:15\u201322","journal-title":"Breast"},{"key":"6025_CR6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1055-9965.EPI-08-0201","volume":"17","author":"W Dong","year":"2008","unstructured":"Dong W, Berry DA, Bevers TB, Kau SW, Hsu L, Theriault RL, Shen Y (2008) Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson cancer center experience. Cancer Epidemiol Biomark Prev 17:1096\u20131103","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/jnci\/dji239","volume":"97","author":"Y Shen","year":"2005","unstructured":"Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA (2005) Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 97:1195\u20131203","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjc.6604368","volume":"98","author":"GC Wishart","year":"2008","unstructured":"Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duffy SW (2008) Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer 98:1741\u20131744","journal-title":"Br J Cancer"},{"key":"6025_CR9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-12-1208-T","volume":"22","author":"N Houssami","year":"2013","unstructured":"Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL (2013) Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomark Prev 22:946\u2013961","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13058-014-0417-7","volume":"16","author":"NF Boyd","year":"2014","unstructured":"Boyd NF, Huszti E, Melnichouk O, Martin LJ, Hislop G, Chiarelli A, Yaffe MJ, Minkin S (2014) Mammographic features associated with interval breast cancers in screening programs. Breast Cancer Res 16:417","journal-title":"Breast Cancer Res"},{"key":"6025_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2014.58.9986","volume":"33","author":"J Holm","year":"2015","unstructured":"Holm J, Humphreys K, Li J, Ploner A, Cheddad A, Eriksson M, Tornberg S, Hall P, Czene K (2015) Risk factors and tumor characteristics of interval cancers by mammographic density. J Clin Oncol 33:1030\u20131037","journal-title":"J Clin Oncol"},{"key":"6025_CR12","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/ijc.21742","volume":"118","author":"S Hofvind","year":"2006","unstructured":"Hofvind S, Moller B, Thoresen S, Ursin G (2006) Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens. Int J Cancer 118:3112\u20133117","journal-title":"Int J Cancer"},{"key":"6025_CR13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/aje\/kwu474","volume":"181","author":"BL Sprague","year":"2015","unstructured":"Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, Remington PL, Newcomb PA, Trentham-Dietz A (2015) Variation in breast cancer-risk factor associations by method of detection: results from a series of case-control studies. Am J Epidemiol 181:956\u2013969","journal-title":"Am J Epidemiol"},{"key":"6025_CR14","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/cncr.101970","volume":"94","author":"EE Calle","year":"2002","unstructured":"Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, Mccullough ML, Feigelson HS, Thun MJ (2002) The american cancer society cancer prevention study II nutrition cohort: rationale, study design, and baseline characteristics. Cancer 94:2490\u20132501","journal-title":"Cancer"},{"key":"6025_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/oxfordjournals.aje.a116664","volume":"137","author":"EE Calle","year":"1993","unstructured":"Calle EE, Terrell DD (1993) Utility of the national death index for ascertainment of mortality among cancer prevention study ii participants. Am J Epidemiol 137:235\u2013241","journal-title":"Am J Epidemiol"},{"key":"6025_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1055-9965.EPI-12-1050","volume":"22","author":"X Xue","year":"2013","unstructured":"Xue X, Kim MY, Gaudet MM, Park Y, Heo M, Hollenbeck AR, Strickler HD, Gunter MJ (2013) A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies. Cancer Epidemiol Biomark Prev 22:275\u2013285","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR17","doi-asserted-by":"crossref","first-page":"e181771","DOI":"10.1001\/jamaoncol.2018.1771","volume":"4","author":"MJ Schoemaker","year":"2018","unstructured":"Premenopausal Breast Cancer Collaborative G, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O\u2019brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ (2018) Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol 4:e181771","journal-title":"JAMA Oncol"},{"key":"6025_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10654-017-0346-8","volume":"33","author":"L Liu","year":"2017","unstructured":"Liu L, Nevo D, Nishihara R, Cao Y, Song M, Twombly TS, Chan AT, Giovannucci EL, Vanderweele TJ, Wang M, Ogino S (2017) Utility of inverse probability weighting in molecular pathological epidemiology. Eur J Epidemiol 33:381\u2013392","journal-title":"Eur J Epidemiol"},{"key":"6025_CR19","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","volume":"304","author":"RT Chlebowski","year":"2010","unstructured":"Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL (2010) Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 304:1684\u20131692","journal-title":"JAMA"},{"key":"6025_CR20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, Lacroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O\u2019sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women\u2019s Health Initiative Steering C (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women\u2019s health initiative randomized controlled trial. JAMA 291:1701\u20131712","journal-title":"JAMA"},{"key":"6025_CR21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.1511","volume":"94","author":"H Wang","year":"2001","unstructured":"Wang H, Bjurstam N, Bjorndal H, Braaten A, Eriksen L, Skaane P, Vitak B, Hofvind S, Thoresen SO (2001) Interval cancers in the norwegian breast cancer screening program: Frequency, characteristics and use of HRT. Int J Cancer 94:594\u2013598","journal-title":"Int J Cancer"},{"key":"6025_CR22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10552-010-9541-6","volume":"21","author":"L Domingo","year":"2010","unstructured":"Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martinez J, Macia F, Quintana MJ, Albanell J, Castells X (2010) Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control 21:1155\u20131164","journal-title":"Cancer Causes Control"},{"key":"6025_CR23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djr138","volume":"103","author":"VA Kirsh","year":"2011","unstructured":"Kirsh VA, Chiarelli AM, Edwards SA, O\u2019malley FP, Shumak RS, Yaffe MJ, Boyd NF (2011) Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst 103:942\u2013950","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/92.9.743","volume":"92","author":"FD Gilliland","year":"2000","unstructured":"Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR (2000) Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92:743\u2013749","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR25","first-page":"1133","volume":"7","author":"NF Boyd","year":"1998","unstructured":"Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomark Prev 7:1133\u20131144","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx001","author":"C Byrne","year":"2017","unstructured":"Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G, Mctiernan A, Chlebowski RT, Lane DS, Manson JE, Wactawski-Wende J, Pisano ED (2017) Mammographic density change with estrogen and progestin therapy and breast cancer risk. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx001","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","volume":"97","author":"A Mctiernan","year":"2005","unstructured":"Mctiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women\u2019s Health Initiative Mammogram Density Study I (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women\u2019s health initiative randomized trial. J Natl Cancer Inst 97:1366\u20131376","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","volume":"95","author":"GA Greendale","year":"2003","unstructured":"Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30\u201337","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","volume":"138","author":"PA Carney","year":"2003","unstructured":"Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168\u2013175","journal-title":"Ann Intern Med"},{"key":"6025_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227\u2013236","journal-title":"N Engl J Med"},{"key":"6025_CR31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","volume":"130","author":"GA Greendale","year":"1999","unstructured":"Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E (1999) Effects of estrogen and estrogen-progestin on mammographic parenchymal density. postmenopausal estrogen\/progestin interventions (PEPI) investigators. Ann Intern Med 130:262\u2013269","journal-title":"Ann Intern Med"},{"key":"6025_CR32","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/aje\/kwp304","volume":"170","author":"NR Cook","year":"2009","unstructured":"Cook NR, Rosner BA, Hankinson SE, Colditz GA (2009) Mammographic screening and risk factors for breast cancer. Am J Epidemiol 170:1422\u20131432","journal-title":"Am J Epidemiol"},{"key":"6025_CR33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13058-017-0922-6","volume":"19","author":"K Ghosh","year":"2017","unstructured":"Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, Frost MH, Hartmann LC, Degnim AC, Vachon CM (2017) Association between mammographic breast density and histologic features of benign breast disease. Breast Cancer Res 19:134","journal-title":"Breast Cancer Res"},{"key":"6025_CR34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-018-4735-9","volume":"170","author":"MS Rice","year":"2018","unstructured":"Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM (2018) Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat 170:129\u2013141","journal-title":"Breast Cancer Res Treat"},{"key":"6025_CR35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jnci\/djt124","volume":"105","author":"JA Tice","year":"2013","unstructured":"Tice JA, O\u2019meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105:1043\u20131049","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fonc.2019.00765","volume":"9","author":"T Agurs-Collins","year":"2019","unstructured":"Agurs-Collins T, Ross SA, Dunn BK (2019) The many faces of obesity and its influence on breast cancer risk. Front Oncol 9:765","journal-title":"Front Oncol"},{"key":"6025_CR37","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/jnci\/djn388","volume":"100","author":"K Kerlikowske","year":"2008","unstructured":"Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS (2008) Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 100:1724\u20131733","journal-title":"J Natl Cancer Inst"},{"key":"6025_CR38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11606-009-0939-3","volume":"24","author":"NM Maruthur","year":"2009","unstructured":"Maruthur NM, Bolen S, Brancati FL, Clark JM (2009) Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med 24:665\u2013677","journal-title":"J Gen Intern Med"},{"key":"6025_CR39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1055-9965.EPI-16-0499","volume":"26","author":"K Krishnan","year":"2017","unstructured":"Krishnan K, Baglietto L, Stone J, Simpson JA, Severi G, Evans CF, Macinnis RJ, Giles GG, Apicella C, Hopper JL (2017) Longitudinal study of mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomark Prev 26:651\u2013660","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/aje\/kwn063","volume":"167","author":"LE Kelemen","year":"2008","unstructured":"Kelemen LE, Pankratz VS, Sellers TA, Brandt KR, Wang A, Janney C, Fredericksen ZS, Cerhan JR, Vachon CM (2008) Age-specific trends in mammographic density: the Minnesota breast cancer family study. Am J Epidemiol 167:1027\u20131036","journal-title":"Am J Epidemiol"},{"key":"6025_CR41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10552-016-0722-9","volume":"27","author":"MC Busana","year":"2016","unstructured":"Busana MC, De Stavola BL, Sovio U, Li J, Moss S, Humphreys K, Dos-Santos-Silva I (2016) Assessing within-woman changes in mammographic density: a comparison of fully versus semi-automated area-based approaches. Cancer Causes Control 27:481\u2013491","journal-title":"Cancer Causes Control"},{"key":"6025_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/aje\/kws446","volume":"178","author":"M Lokate","year":"2013","unstructured":"Lokate M, Stellato RK, Veldhuis WB, Peeters PH, Van Gils CH (2013) Age-related changes in mammographic density and breast cancer risk. Am J Epidemiol 178:101\u2013109","journal-title":"Am J Epidemiol"},{"key":"6025_CR43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/1055-9965.EPI-05-0798","volume":"15","author":"G Maskarinec","year":"2006","unstructured":"Maskarinec G, Pagano I, Lurie G, Kolonel LN (2006) A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomark Prev 15:732\u2013739","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6025_CR44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ijc.25252","volume":"127","author":"VA Mccormack","year":"2010","unstructured":"Mccormack VA, Perry NM, Vinnicombe SJ, Dos Santos Silva I (2010) Changes and tracking of mammographic density in relation to pike\u2019s model of breast tissue aging: a UK longitudinal study. Int J Cancer 127:452\u2013461","journal-title":"Int J Cancer"},{"key":"6025_CR45","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.amepre.2013.10.031","volume":"46","author":"C Scoccianti","year":"2014","unstructured":"Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu I (2014) Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med 46:S16-25","journal-title":"Am J Prev Med"},{"key":"6025_CR46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bjc.2011.254","volume":"105","author":"TJ Key","year":"2011","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE, Strickler HD (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105:709\u2013722","journal-title":"Br J Cancer"},{"key":"6025_CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/WHE.14.62","volume":"11","author":"Y Liu","year":"2015","unstructured":"Liu Y, Nguyen N, Colditz GA (2015) Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health (Lond) 11:65\u201377","journal-title":"Womens Health (Lond)"},{"key":"6025_CR48","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-18-0502","volume":"78","author":"MM Gaudet","year":"2018","unstructured":"Gaudet MM, Gierach GL, Carter BD, Luo J, Milne RL, Weiderpass E, Giles GG, Tamimi RM, Eliassen AH, Wolk A, Adami HO, Margolis KL, Gapstur SM, Garcia-Closas M, Brinton LA (2018) Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Cancer Res 78:6011\u20136021","journal-title":"Cancer Res"},{"key":"6025_CR49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/aje\/kwv086","volume":"182","author":"M Garcia-Closas","year":"2015","unstructured":"Garcia-Closas M, Berrington De Gonzalez A (2015) Invited commentary: screening and the elusive etiology of prostate cancer. Am J Epidemiol 182:390\u2013393","journal-title":"Am J Epidemiol"},{"key":"6025_CR50","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/aje\/kwg063","volume":"157","author":"MM Joffe","year":"2003","unstructured":"Joffe MM (2003) Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations. Am J Epidemiol 157:962\u2013964","journal-title":"Am J Epidemiol"},{"key":"6025_CR51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/aje\/kwg064","volume":"157","author":"NS Weiss","year":"2003","unstructured":"Weiss NS (2003a) Weiss responds to \u201cscreening as a nuisance variable in cancer epidemiology\u201d: for which aspects of a study subject\u2019s screening history should we control? Am J Epidemiol 157:965","journal-title":"Am J Epidemiol"},{"key":"6025_CR52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/aje\/kwg062","volume":"157","author":"NS Weiss","year":"2003","unstructured":"Weiss NS (2003b) Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol 157:957\u2013961","journal-title":"Am J Epidemiol"},{"key":"6025_CR53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/tbj.12622","volume":"22","author":"T Bian","year":"2016","unstructured":"Bian T, Lin Q, Cui C, Li L, Qi C, Fei J, Su X (2016) Digital breast tomosynthesis: a new diagnostic method for mass-like lesions in dense breasts. Breast J 22:535\u2013540","journal-title":"Breast J"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-06025-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T13:22:13Z","timestamp":1670678533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-06025-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6025"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06025-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Emory University School of Medicine Institutional Review Board approves all aspects of Cancer Prevention Study-II Nutrition Cohort.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for participation was assumed based on completion and return of study questionnaires.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}